title: [Metastatic colorectal cancer: adjournments from ESMO 2006].
authors.affiliation: Dell'Unità Operativa Complessa di Oncologia Medica, Ospedale Mater Salutis, Legnago, VR.
authors.forename: Andrea
authors.initials: A
authors.lastname: Bonetti
authors.forename: Stefano
authors.initials: S
authors.lastname: Cascinu
authors.forename: Alfredo
authors.initials: A
authors.lastname: Falcone
authors.forename: Evaristo
authors.initials: E
authors.lastname: Maiello
authors.forename: Alberto
authors.initials: A
authors.lastname: Zaniboni
authors.forename: Carlo
authors.initials: C
authors.lastname: Aschele
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000068258:Bevacizumab; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives; D000069287:Capecitabine; D000068818:Cetuximab; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D004334:Drug Administration Schedule; D005060:Europe; D005472:Fluorouracil / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D000077146:Irinotecan; D002955:Leucovorin / Q000008:administration & dosage; D008495:Medical Oncology; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D000077150:Oxaliplatin; D000077544:Panitumumab; D012955:Societies, Medical
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D003841:Deoxycytidine; D000068258:Bevacizumab; D000069287:Capecitabine; D000077544:Panitumumab; D000077146:Irinotecan; D000068818:Cetuximab; D002955:Leucovorin; D005472:Fluorouracil; D002166:Camptothecin